GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B5636 CS 2100Summary: S1P1 agonist
- B5680 CYM 50260Summary: S1P4 agonist
- B5681 CYM 50308Summary: S1P4 agonist
- B5682 CYM 50358 hydrochlorideSummary: S1P4 antagonist
- B5701 TC-G 1006Summary: sphingosine-1-phosphate receptor 1 (S1P1) agonist
- B5755 CYM 5541Summary: sphingosine-1-phosphate receptor 3 (S1P3) allosteric agonist
- C3924 2-fluoro Palmitic AcidSummary: inhibits sphingosine biosynthesis and long-chain acyl-CoA synthetase
- C4236 FTY720 PhosphateSummary: sphingosine-1-phosphate (S1P) receptors agonist
- C4064 W123Summary: S1P1 antagonist
- C4287 ML-178Summary: S1P4 activator